Selected article for: "epidemiological information and infection control"

Author: Sahu, Ankit Kumar; Nayer, Jamshed; Aggarwal, Praveen
Title: Novel coronavirus: A capsule review for primary care and acute care physicians
  • Cord-id: 4t8etkdl
  • Document date: 2020_4_30
  • ID: 4t8etkdl
    Snippet: Novel coronavirus (nCoV) is a new emerging infectious agent causing coronavirus disease 2019 (COVID-19). Since the reporting of early cases of COVID-19 from China on December 29, 2019 till March 15, 2020, it has affected 1,42,539 humans in 135 countries, including 82 cases in India. As it is a difficult task for first-contact physicians, i.e. primary care and acute care physicians, to comprehend the fast-growing knowledge about nCoV and apply for prevention and care of suspected cases of COVID-1
    Document: Novel coronavirus (nCoV) is a new emerging infectious agent causing coronavirus disease 2019 (COVID-19). Since the reporting of early cases of COVID-19 from China on December 29, 2019 till March 15, 2020, it has affected 1,42,539 humans in 135 countries, including 82 cases in India. As it is a difficult task for first-contact physicians, i.e. primary care and acute care physicians, to comprehend the fast-growing knowledge about nCoV and apply for prevention and care of suspected cases of COVID-19, we have tried to provide an updated capsule review of nCoV infection and management of COVID-19. It includes the evidence-based information on epidemiological determinants (agent, host, and environment) of the disease, its clinical features, clinical and laboratory diagnosis, basic infection prevention and control measures, and clinical management of COVID-19 cases. This review also includes the succinct summary of World Health Organization and Center for Diseases Control and Prevention interim guidelines (as of March 15, 2020) on nCoV.

    Search related documents:
    Co phrase search for related documents
    • acute care and local health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute care and local transmission: 1
    • acute care and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
    • acute care and low tidal volume: 1, 2, 3, 4, 5
    • acute care and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute sars cov respiratory syndrome coronavirus and live animal: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute sars cov respiratory syndrome coronavirus and local health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and local transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and low tidal volume: 1, 2
    • acute sars cov respiratory syndrome coronavirus and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • live animal and local transmission: 1
    • live animal and lopinavir ritonavir: 1
    • local transmission and lopinavir ritonavir: 1
    • lopinavir ritonavir and lung involvement: 1, 2, 3, 4, 5